Although many patients suspected of suffering disturbances of the mitochondrial energy metabolism have been investigated, only a fraction of these patients have been diagnosed at the molecular level. Introduction of new techniques like proteomics will be necessary to understand the various clinical and biochemical aberrations in the eld of mitochondrial disorders. Two-dimensional electrophoresis is rst, important step in the proteomics strategy. Separation of soluble proteins is performed on the basis of isoelectric point (net charge) in one direction and on molecular mass in the other. The technique provides an overview of the majority of proteins expressed in a sample (e.g. muscle biopsy, muscle cell or mitochondrial fraction). Once an abnormal spot is observed in the gel the responsible protein can be identi ed by analysing a limited part of its amino acid sequence by mass spectrometry. We optimized two-dimensional (2D) gel electrophoresis to obtain high resolution 2D-maps and tested the reproducibility of the technique. Potentially, this new technique is capable of identifying novel mitochondrial diseases and de ning their molecular basis.
The perceived ultimate goal of identifying and sequencing the approximately 32 000 genes of the human genome has reached the end of the ¢rst phase. Functional and structural genomics projects have now begun, using the genetic sequences to predict the resultant proteins and to investigate their structure and function. This information will contribute greatly to biology and medicine, but already the idea of one gene to one protein is known not to hold. Preliminary studies suggest that the average number of protein forms per gene is one to two in bacteria, three in yeasts and three to six or more in human beings. Organisms are far more complex than is indicated by analysis of genetic material alone. Alternatively, examination of the functional output, or proteome, the expressed protein complement of a genome and also that of a tissue or cell type, additional complementary information can be obtained, which will allow the clinical bene¢ts of the new knowledge to be fully realised.
The major challenge facing the medical research community is to use the wealth of genetic information available from the genome-sequencing programme not just to decode the amino acid sequence of the encoded proteins, but also to discover their function. Genomic-based approaches initially use computerbased similarity searches against proteins of known function. The results may allow some broad inferences to be made about possible functions, which can then be explored experimentally. However, about a third of the sequences in organisms for which the genomes have been sequenced seem to code for proteins that are unrelated at this level to proteins of known function. In addition to the genetic make-up of an individual or organism determining protein expression, many other factors determine gene and ultimately protein expression and a¡ect proteins directly. These factors include cellular and environmental factors such as pH, hypoxia and drug administration. Similarly, because the £ow of information between genes and proteins is bidirectional, the cellular phenotype is in£uenced by the networks created by interaction between pathways that are regulated in a coordinated way or that overlap. Neither these e¡ects, nor the biological basis of multigenic processes such as ageing, stress and disease, can be identi¢ed solely from examination of the genome. Further insights into possible roles of Personal View particular genes in disease can be obtained from results of various techniques such as nucleic-acidbased microarray technology, which is increasingly used to characterize di¡erences in mRNA populations between diseased and normal tissue.
There are several other compelling reasons to complement these studies and approach biological questions from the protein perspective to provide both qualitative and quantitative information about gene expression^i.e. proteomics. Proteins are the functional output of the cell and therefore might be expected to provide the most relevant information, particularly when interpretation of their expression takes into account their dynamics in speci¢c biological contexts. The expression or function of proteins is modulated at many points from transcription to posttranslational modi¢cations (see Fig. 1 ), which generally cannot be predicted from analysis of nucleic acids alone. There is poor correlation between the abundance of mRNA transcribed from the DNA and the respective proteins translated from that mRNA. 1 The transcript can be spliced in various ways to yield di¡erent protein forms. Extensive changes can also be introduced during or after translation leading to multiple protein products from a single gene. For all these reasons proteomics-based approaches, which examine the expressed proteins of a tissue, cell type or cell organel, are increasingly being used to address biomedical questions.
Proteome analysis
Proteome analysis (proteomics) is de¢ned as the analysis of the protein complement expressed by a genome. It has been suggested as an approach for the quantitative description at protein level of the state of a biological system. 2 It can provide information that cannot be derived from DNA or RNA sequence analysis alone, such as the quantity of proteins expressed, their subcellular localization, their possible modi¢cations, and the tissue-speci¢c and/or development-speci¢c changes in these properties.
The central tool for displaying the proteome is twodimensional gel electrophoresis (2DGE). The isoelectric point (or pI) of a protein is the pH at which its net charge of the protein is zero (under non-denaturing conditions, the net charge of the protein is dependent on the basic and acid content of the protein). At this pH, the electrophoretic mobility of the protein is zero. When a mixture of proteins is electrophoresed in a pH gradient, each protein will migrate until it reaches a position in the gel at which the pH is equal to its isoelectric point. This method is called isoelectric focusing (IEF).While IEF separates proteins according to their isoelectric point, sodium dodecyl sulphate (SDS)-polyacrylamide gel electrophoresis separates proteins according to their molecular mass (M r ). This is performed in the presence of SDS, which disrupts nearly all non-convalent interactions in the native protein. Anions of SDS bind to the polypeptide chain in a ratio of about one SDS molecule to every two amino acid residues, which gives the SDS-denatured protein a net negative charge that is roughly proportional to the molecular mass of the protein.
The concept of mapping the human proteome by 2DGE was put forward almost 30 years ago. In 1975, O'Farell 3 and Klose 4 independently developed and published two slightly di¡erent procedures for 2DGE. The two procedures di¡ered primarily in the sample loading side of the gel. Both procedures aimed to separate the proteins according to their pI in the ¢rst dimension and according to their M r in the second dimension. Therefore, the protein sample is ¢rst subjected to IEF. This single -lane gel is then placed horizontally on top of a SDS-polyacrylamide slab gel on which the proteins are electrophoresed again, but this time in a direction perpendicular to that of the IEF. Several hundreds 3, 4 to 1000 4 proteins of a whole cell extract could be separated in this way on a single gel. This technique has subsequently attracted the attention of many researchers in the hope that complex biochemical processes could be analysed in a single experimental setting.
A number of methods have been described for the detection and/or identi¢cation of proteins separated by 2DGE. Methods such as silver staining, 5 Western blotting experiments, 6 gene overexpression, 7 partial protein sequencing, 8, 9 and amino acid composition determination 10, 11 have contributed to the characterization of cellular proteins. However, these methods are slow because of the amount of work these methods require. Since the late 1980s, mass spectrometry has been applied for characterization. Recent advances in the ¢eld of mass spectrometry have dramatically enhanced the throughput and sensitivity of protein identi¢cation that is not feasible with large-scale 2DGE mass spectrometry (MS)-based proteome analysis. 12, 13 Proteomics to study neuromuscular diseases Two-dimensional electrophoresis is the ¢rst, important step in our proteomics strategy. The sample (e.g. muscle biopsy, muscle cell or mitochondrial fraction) is solubilized, and the proteins are denatured into their polypeptide subunits. Proteins are separated on the basis of their charge (IEF) in the ¢rst dimension and molecular mass (SDS polyacrylamide gel electrophoresis) in the second. The technique provides an overview of the majority of proteins expressed in the sample. Multiple forms of individual proteins can be readily visualiz ed, e.g. by staining with silver, 13 and characterized by factors such as initial choice of conditions of sample solubilization conditions and pH range of the gel strip used for the ¢rst dimension. Analysis of gel images with specializ ed software allows comparison of multiple gels both within a laboratory and, via links, to comprehensive proteome databases on the internet. Thus, by a process of subtraction, di¡erences (e.g. presence, absence, or intensity of proteins or di¡erent forms) between healthy and diseased samples can be revealed. Proteins of interest can then be identi¢ed on the basis of the isoelectric point and apparent molecular size determined from the 2D gels, supplemented by a combination of methods, generally applied hierarchically. Increasingly, these include highly sensitive mass-spectrometric methods [Maldi Assisted Desorption Ionization Time of Flight (MALDI-TOF) and/or Quadripule Time of Flight (QTOF)], which require smaller amounts of material and have a higher throughput than conventional sequencing methods (sensitivity of femtomole to attomole concentrations). Proteins or peptides (obtained via a tryptic digest from a protein taken directly from the 2D-gel) are ionized by electrospray ionization from liquid state or matrixassisted laser desorption ionization from solid state, and the mass of the ions is measured very accurately by various coupled analysers. For example, a time -of-£ight analyser measures the time for ions to travel from the source to the detector. If necessary, actual sequence information can be obtained by tandem mass spectrometry, in which discrete peptide ions can be selected and fragmented, and complex algorithms are used to correlate the experimental data with data derived from peptide sequences in internationally accessible protein databases (e.g. the`Swiss -Protein' database). Other relevant databases include: the Expressed Sequence Tag (EST) database, which lists the proteins that are expressed in human skeletal muscle tissue; the`two-dimensional gel electrophoresis protein database'; and`Heart-2D-PAGE', which is available through the internet and which provides the relevant physicochemical characteristics of part of the human heart proteins (http://www.mdc-berlin.de/ ¹emu/heart/) including several mitochondrial proteins (e.g. superoxide dismutase, cytochrome c oxidase polypeptide VA and VIB).
Proteomics as a strategy became feasible due to recent technical advances:
(a) The development and commercial availability of polyacrylamide gels with immobilines, providing a highly reproducible pH-gradient in the gel. This ensures that the coordinates of each protein will vary only minimally from gel to gel, thus making the identi¢cation easier. 
Two-dimensional gel electrophoresisbased proteome analysis: limits and implications
Two-dimensional gel electrophoresis-based proteome analysis is a multi-step process and errors can be introduced in many of these steps. Figure 2 displays the entire process and points out those steps where errors may occur. Recognizing the error-prone nature of the technology becomes exceedingly important when performing quantitative proteomics, in which the relative quantities of the di¡erent proteins rather than their identity is important. A major concern among scientists applying the 2DGE technology to display a proteome is the reproducibility of the resulting patterns. The main reason why the various attempts to construct a general (yeast) 2DGE-based proteome database have not yet succeeded is the lack of reproducibility of results provided by di¡erent groups. This lack of reproducibility is caused by the introduction of errors in the process, but also by the fact that there is as yet no agreement among di¡erent groups on running conditions. With the introduction of immobilize d pH gradients (IPG), errors due to irregularities in preparing the IEF gels are minimized. 14 This is not only important for the quality of the resulting 2D pattern but also for its reproducibility in di¡erent laboratories using di¡erent equipment and chemicals.
Sample preparation (e.g. tissue homogenate, cell lysate) is one of the most crucial points in the whole procedure of 2DGE. For quantitative proteomics the emphasis on this point is even greater, since the ¢nal pattern should represent the whole cellular protein content properly. This is because, in contrast to studies on a single or particular set of proteins that represent a de¢ned part of the physiology of a cell, quantitative proteomics is meant to address high-order regulatory processes involving tens to several hundreds or even thousands of proteins. These di¡erent proteins can have various molecular environments and/or physical properties that might a¡ect quantitative studies of their expression. Any conclusion based on an improper representation of these proteins will be simply incorrect. For more details concerning the representation of di¡erent cellular proteins in 2D gels the reader is referred to the studies of Garrels et al. 15 Ann Clin Biochem 2003; 40: 9-15 Figure 2 . A schematic representation of a general procedure for two-dimensional gel electrophoresis-based quantitative proteomics. The different steps of the procedure are given and the steps where errors may occur are indicated.
Preliminary proteomics data from Nijmegen
To set up proteomics to study neuromuscular diseases, we ¢rst aimed to obtain an overall view of the soluble proteins expressed in human skeletal muscle, using a proteomics strategy. Essential steps in the project are: We divided one quadriceps muscle sample in two equal fractions, and performed the sample preparation and 2DGE in two separate experiments (with a time interval of 1 week). Subsequently, the two 2D gels obtained were stained with silver and analysed with the help of specialized computer software to allow comparison of multiple protein spots in the di¡erent 2D gels (see Fig. 3 ). More than 95% of the spots were observed in both gels. Aberrant spots (e.g. proteins present in just one 2D gel) represented only low abundant proteins.
At present we are determining normal expression patterns of proteins in skeletal muscle samples originating from di¡erent donors, di¡erent sexes and at di¡erent ages. Considerable experience is required and many control samples have to be analysed before this can be interpreted reliably. Proteomics provides an overview of the majority of proteins expressed in muscle tissue. Aberrant migration behaviour of a particular protein in 2D gels may have clinical relevance, but may also be caused by innocent polymorphisms. The number of proteins also complicates the interpretation (in mitochondria at least 1000 di¡erent proteins are expressed). At the moment, the number of analysed samples is too limited to present reliable data.
Future perspectives for the eld of mitochondriopathies
The aim of this novel approach is to gain new insight into the pathophysiology of neuromuscular disorders. Proteomics uses the physicochemical properties of proteins for their identi¢cation. Proteins are separated on the basis of their pI and their molecular mass. Subsequently, mass spectrometry can identify the protein. The technique allows an overall view on soluble proteins in a cell type or tissue sample. It has been estimated that 480% of the soluble proteins that are expressed in a cell may be detected with this approach. 13, 16 However, low abundant proteins may remain below the detection limit of the technique. 16 Proteomics may identify proteins with abnormal physicochemical characteristics due to an abnormal amino acid composition. Also, proteins that are present in abnormal quantities in a speci¢c patient can be detected. 17 In patients suspected of su¡ering a mitochondrial disorder, muscle biopsy is a common diagnostic procedure. In the Nijmegen Center for Mitochondrial Disorders more than 300 muscle biopsies are performed on an annual base. Applying the proteomics strategy to muscle biopsy samples is a new diagnostic approach for mitochondrial disorders. As gene defects usually in£uence the protein's physicochemical characteristics, proteomics may be used to obtain evidence for the molecular defect underlying the disease. Whereas classical techniques generally use the metabolite level as a ¢rst diagnostic approach, proteomics will open up new diagnostic dimensions by approaching diagnosis at the protein level. A recent study showed that in 30^40% of the cases admitted for investigations, the diagnosis, in spite of all investigations performed (clinical, histological, biochemical and/or molecular genetic), was`mitochondriocytopathy, unspeci¢ed'. Potentially, this new technique is capable of identifying some novel mitochondrial diseases and de¢ning their molecular basis.
